Category: Series
-
While your Bitcoin and Dogecoin shredded, MARV, GMX, CYBN, GLM, GMTN, and PINK doubled: Diversify, children!
Who’s a boomer now, Dogetards? For a few months there, a legion of newly minted investors, convinced they invented daytrading with their stimulus cheques and chicken tendies, watched their $500 investments run to new heights, taking AMC Cinemas (AMC.Q) to a $28 billion valuation, and driving Bitcoin and Dogecoin to stupid new highs. It was…
-
![Is it weird to talk about suicide, addiction and PTSD in the same breath as stonks and tendies?]()
Is it weird to talk about suicide, addiction and PTSD in the same breath as stonks and tendies?
“Suicide Opportunity” I can’t remember what company it was, maybe MindMed, but one of their early pitch decks had a page titled ‘Suicide Opportunity’. Yesterday I wrote an article outlining how Seelos Therapeutics was targetting suicide with ketamine-based treatments and it reminded me for a moment of that pitch deck. To note, Seelos didn’t word…
-
Arizona Metals (AMC.V): How Equity.Guru helped you find an 8-bagger
All too often, we write a story about a company, the company does well, stock goes up, people make money and then we move on without celebrating our wins. Today I figured it was worth going the other way and doing a ‘success forensic,’ because when you manage to pick an 8-bagger, it makes sense…
-
![Medexus Pharmaceuticals (MDP.T) gets the Health Canada official nod to commercialize treosulfan]()
Medexus Pharmaceuticals (MDP.T) gets the Health Canada official nod to commercialize treosulfan
Medexus Pharmaceuticals (MDP.T) received Health Canada’s Notice of Compliance to commercialize treosulfan today, according to a press release. Treosulfan will be sold in Canada using the brand name Trecondyv®. It’s used in combination with another drug called fludarabine as part of a conditioning treatment prior to allogeneic hemapoietic stem cell transplantation. The treatment clears the…
-
![Plurilock Security’s (PLUR.V) brilliant CEO Ian Paterson creates traction in the $1 trillion cybersecurity market through innovation, patents and acquisitions]()
Plurilock Security’s (PLUR.V) brilliant CEO Ian Paterson creates traction in the $1 trillion cybersecurity market through innovation, patents and acquisitions
Some CEOs are good at operations. Some CEOs are good at acquisitions. Some CEOs are good at corporate messaging. Very few are good at all three. Plurilock Security (PLUR.V) CEO Ian Paterson is an example of a CEO who has these three skills. On June 29, 2021 PLUR provided a corporate update for the first…
-
![Why your crypto bets are down and what’s to be done?]()
Why your crypto bets are down and what’s to be done?
Bitcoin’s down almost half of its high point mark achieved earlier this year, and naysayers are chuckling about the things they’ve always known about the currency. Like they always do whenever crypto hits the skids, which it does ever so often. It’s a common occurrence, and common enough that folks involved will keep quiet during…
-
![X-Terra (XTT.V) probes the subsurface stratum at Troilus East Project in mining-friendly Québec – assays are pending]()
X-Terra (XTT.V) probes the subsurface stratum at Troilus East Project in mining-friendly Québec – assays are pending
It’s difficult to overstate the importance of a project’s zip code when shortlisting stocks in the junior exploration arena. High-risk jurisdictions—those with twitchy governments at the helm—have been known to put the kibosh on mining claims, development projects, and even operating mines once all of the heavy-lifting is done. Venezuela, Kyrgyzstan, Zambia, Zimbabwe, Bolivia… the…
-
![Bioasis Technologies (BTI.V) and The Lind Partners come to financing deal]()
Bioasis Technologies (BTI.V) and The Lind Partners come to financing deal
Bioasis Technologies (BTI.V) entered into a convertible security financing earlier this week with New-York based investment management firm, Lind Global Macro Fund, a subsidiary of The Lind Partners, according to a press release. The terms of the agreement give Bioasis the ability to issue convertible securities up to $10 million with proceeds going to general…
-
![Bioasis Technologies (BTI.V) and the painful price of private sector science]()
Bioasis Technologies (BTI.V) and the painful price of private sector science
Science isn’t cheap. Overhead for scientific based companies is usually sky high for a reason. It’s not just keeping the lights on, or making sure everyone from the CEO to the janitorial staff get paid on time, although that’s part of it. It’s revolving costs in equipment, other forms of capital—like human capital—the average science…
-
![Plurilock (PLUR.V) just keeps piling up orders from California government agencies]()
Plurilock (PLUR.V) just keeps piling up orders from California government agencies
Do you ever feel like you keep running round the same old ground, repeating the same thing over and over? Well, welcome to me life right now, because I’m here to tell you, as I do every week, that Plurilock Security (PLUR.V) has received a purchase order from yet another government agency in California. This…
